Alembic Pharmaceuticals Receives USFDA Approval for Binimetinib Tablets
Alembic Pharmaceuticals has received final USFDA approval for binimetinib tablets in 15 mg and 45 mg strengths and is eligible for 180 days of generic drug exclusivity.
Mektovi Tablets | 17/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy